Active, Not Recruiting
Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors
NCT03967223
- Conditions
- Liposarcoma, Liposarcoma, Myxoid, Neoplasms, +6 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Stanford Hospital and Clinics Stanford, California, United States
- Sarah Cannon Research Institute Denver, Colorado, United States
- Mayo Clinic Jacksonville Jacksonville, Florida, United States